Allspring Global Investments
SURF

Allspring Global Investments’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Allspring Global Investments’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-173,691
Closed -$510K – 3022
2022
Q1 		$510K Buy
173,691
+32,430
+23% +$114K ﹤0.01% 2209
2021
Q4 		$675K Buy
+141,261
New +$912K ﹤0.01% 2162

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Allspring Global Investments's SURF Position: Q2 2022 in Review

Allspring Global Investments sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2022, closing a stake of 173,691 shares — an estimated $510K sold.

Allspring Global Investments first reported a position in SURF in Q4 2021 and held it in 2 quarters. The position peaked at $675K in Q4 2021. 84 funds tracked by Wall St. Rank hold SURF as of Q2 2022.

  • Allspring Global Investments reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Allspring Global Investments sold 173,691 Surface Oncology, Inc. Common Stock shares in Q2 2022, an estimated $510K.
  • Allspring Global Investments first reported a position in Surface Oncology, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Allspring Global Investments's Surface Oncology, Inc. Common Stock position peaked at $675K in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2022.

Based on Allspring Global Investments's 13F filing for Q2 2022, filed 25 Jul 2022.